The Effects of Corneal Collagen Cross-linking

Status unconfirmed · Phase 3

Conditions studied: Corneal Ectasia Disorders Including Keratoconus

In brief

The corneal collagen cross-linking treatment has been used with increasing success to treat corneal dystrophies such as "keratoconus." Recent advances have allowed different techniques for performing this cross-linking treatment. This study investigates the effects of corneal cross-linking using different surgical techniques.

Key facts

Study ID

NCT01708538

Run by

Rush Eye Associates

People needed

30

Starts

2012-10-01

Expected to finish

2024-10-01

Last updated by the study team

2022-10-26

Who can join

Age: 10 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 10-70, willing to participate, diagnosis of corneal ectasia disorder

You may not qualify if…

• Unwilling or unable to participate in trial

Where it is running

• Rush Eye Associates — Amarillo, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.